上海赛傲生物

Shanghai Cell-ALL Biological Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine and immune cell therapies. The company has established a comprehensive iCell technology platform that integrates cell storage, research, and standardized manufacturing. Its pipeline includes several mesenchymal stem cell (MSC) candidates for indications such as knee osteoarthritis and liver cirrhosis, as well as CAR-T and NK cell programs for oncology. Cell-ALL also operates as a CDMO, providing specialized manufacturing services for cell and gene therapy developers. With multiple GMP-compliant facilities across China, the company aims to bridge the gap between laboratory research and clinical application.